NCT07590700 Home-Based Exercise Programs for Fall Prevention in Parkinson Disease
| NCT ID | NCT07590700 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Uludag University |
| Condition | PARKINSON DISEASE (Disorder) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-02-08 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-02-08 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Falls are common in patients with Parkinson disease and may lead to reduced mobility, fear of falling, loss of independence, and injury. Exercise-based rehabilitation programs may help improve balance, gait, and physical performance in this population. This randomized controlled trial aims to compare the effectiveness of two home-based exercise programs in patients with Parkinson disease: the Otago Exercise Program and a structured home exercise program. Participants will be randomly assigned to one of two groups. Both groups will receive exercise education and will perform their assigned home exercise program for 6 weeks. Participants will be evaluated at baseline, at week 3, and at the end of week 6. The study will assess fall-related outcomes, freezing of gait, functional mobility, gait parameters, postural control, and physical performance. The results may help determine which home-based exercise approach is more effective for reducing fall risk and improving functional outcomes in patients with Parkinson disease.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Parkinson disease confirmed by a neurologist * Hoehn and Yahr stage 3 or 4 Parkinson disease * Diagnosis of Parkinson disease for at least 5 years * Willingness to participate in the study and provide written informed consent * Ability to walk independently or with minimal assistance * Mini-Mental State Examination score \>24 Exclusion Criteria: * Balance or gait impairment due to causes other than Parkinson disease, such as severe orthopedic problems or another neurological disease * Red flags suggestive of Parkinson-plus syndromes, such as symmetric onset, early falls, early-onset dementia, or gaze palsy * History of serious fall-related injury or surgery within the last 6 months * Any additional health condition that would prevent participation in the exercise program during the study period
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07590700 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying PARKINSON DISEASE (Disorder). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07590700 currently recruiting?
Yes, NCT07590700 is actively recruiting participants. Contact the research team at mgselim1@gmail.com for enrollment information.
Where is the NCT07590700 trial being conducted?
This trial is being conducted at Hatay, Turkey (Türkiye).
Who is sponsoring the NCT07590700 clinical trial?
NCT07590700 is sponsored by Uludag University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.